Please login to the form below

Not currently logged in
Email:
Password:

Antares Pharma

This page shows the latest Antares Pharma news and features for those working in and with pharma, biotech and healthcare.

A matter of urgency

It bought the anticholinergic, Toviaz (fesoterodine) for over $100 million in April 2006 from German company Schwarz Pharma. ... One such is Antares Pharma's Anturol, shown in phase II studies to lead to only minimal dry mouth.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Antares CEO Wotton resigns Antares CEO Wotton resigns

    He will move to Advanced Cell Technology. Antares Pharma CEO Paul Wotton is to resign his position to take over as CEO at development-stage biotech company Advanced Cell Technology. ... His replacement at Antares is Eamonn Hobbs, a current board member

  • Antares appoints David Bergstrom as SVP Antares appoints David Bergstrom as SVP

    Second major appointment in one month. Antares Pharma has appointed Dr David Bergstrom as senior VP of pharmaceutical development. ... He is the second senior VP to join Antares this month after the appointment of former Pfizer VP Dr Bruce Freundlich as

  • Former Pfizer VP joins Antares Former Pfizer VP joins Antares

    Bruce Freundlich appointed senior VP, medical. Antares Pharma has appointed Dr Bruce Freundlich as senior VP, medical. ... Antares Pharma has made several senior appointments in the past year, including a new VP, clinical development, and senior VP,

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics